Wildcat Capital Management

Latest statistics and disclosures from Wildcat Capital Management's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by Wildcat Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Wildcat Capital Management

Wildcat Capital Management holds 7 positions in its portfolio as reported in the September 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Frontier Group Hldgs (ULCC) 73.4 $150M 28M 5.35
 View chart
Rlx Technology Sponsored Ads (RLX) 16.0 $33M 18M 1.81
 View chart
Allogene Therapeutics (ALLO) 4.0 $8.2M 2.9M 2.80
 View chart
Urogen Pharma (URGN) 3.1 $6.3M 496k 12.70
 View chart
Skillz 2.7 $5.5M 980k 5.62
 View chart
Kronos Bio (KRON) 0.6 $1.3M 1.3M 1.00
 View chart
Silexion Therapeutics Corp SHS 0.3 $536k NEW 1.0M 0.53
 View chart

Past Filings by Wildcat Capital Management

SEC 13F filings are viewable for Wildcat Capital Management going back to 2014

View all past filings